Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children

Konca, Çapan; YEL, Servet; BİLEN, Gülseren; GÜRKAN, M. Fuat; GÜNEŞ, Ali; TUTANÇ, Murat

Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children

Murat TUTANÇ, (Dörtçelik Çocuk Hastanesi Pediatri Servisi, Bursa, Türkiye)

M. Fuat GÜRKAN, (Dicle Üniversitesi, Tıp Fakültesi, Diyarbakır, Türkiye)

Servet YEL, (Dicle Üniversitesi, Tıp Fakültesi, Diyarbakır, Türkiye)

Ali GÜNEŞ, (Dicle Üniversitesi, Tıp Fakültesi, Diyarbakır, Türkiye)

Çapan KONCA, (Adıyaman Üniversitesi, Tıp Fakültesi, Adıyaman, Türkiye)

Gülseren BİLEN (Dicle Üniversitesi, Tıp Fakültesi, Diyarbakır, Türkiye)

Journal of Clinical and Analytical Medicine

1 0

Yıl: 2015 Cilt: 6 Sayı: 3 Sayfa Aralığı: 353 - 357 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children

Öz:

Akut solunum yolu enfeksiyonları astımlı çocuk hastalarda akut astım atağını tetikleyebilir ve etyopatogenezde sorumlu tutulabilir. Bakteriyel enfeksiyonlar daha az dikkati çekmekle beraber son zamanlarda özellikle Chlamydiapneumoniae (CP) ve Mycoplasma pneumoniae (MP) olası etken olarak bildirilmektedir. Bronşiyal astımlı (3-14 yaş arası) 66 çocuk hastada CP ve Mycopasma pneumoniae IgM ve IgG seroprevalansı araştırıldı. Toplam 66 olgunun18inde (%27.2) CP IgG, 27sinde (%40.9) MP IgG pozitifiği saptandı. Kontrol grubunun 6sında (%13.0) CP IgG, 6sında (%10.8) MP IgG pozitifiği saptandı. Astım hastalarında MP IgG seropozitifiği olanların oranı kontrol grubunun 4 katı fazlaydı. Daha sık atak geçirenlerde CP IgG antikoru seropozitifiğinin daha fazla olduğu görüldü. M. pneumaniae IgG antikoru seropozitifiği açısından böyle bir farklılığa rastlanmadı. CP ve MP enfeksiyonlarının çocuklarda bronşiyal astım ve astım atağı etyolojisinde önemli yer tuttuğunadair pek çok çalışma vardır. Sonuçlarımız her iki mikroorganizmanın bronşiyal astım etyopatogenezinde ve astım atağı sayısının artışında etkili olduğunu ortaya koymaktadır.

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Bronşiyal astımlı çocuklarda chlamydia pneumoniae ve mycoplasma pneumoniae seropozitifiği

Öz:

Acute respiratory tract infections may trigger acute asthma attacks and maybe held responsible for etiopathogenesis in children with asthma. Althoughbacterial infections attract a limited amount of attention, recently Chlamydiapneumoniae (CP) and Mycoplasma pneumoniae (MP), in particular, are reported to be the possible factors. IgM and IgG seroprevalence was investigated in 66 children patients with bronchial asthma (between the ages of3 and 14) for CP and Mycoplasma pneumoniae. In a total of 66 cases, 18(27.2%) patients were detected with IgG positivity for CP whereas 27 ofthem (40.9%) were detected with IgG positivity for MP. IgG positivity wasdetermined in 6 patients (13.0%) in the control group for CP, and in 6 patients(10.8%) in the control group for MP. The rate of the asthma patients withIgG seropositivity for MP was 4 times higher than that of the control group.It was seen that IgG antibody seropositivity for CP was higher in those withmore frequent attacks. No such diference was observed in terms of IgGantibody seropositivity for M. pneumoniae. There are many studies indicating that CP and MP infections take an importance place in the etiology ofbronchial asthma and asthma attacks in children. The results obtained revealthe efect of both microorganisms on the etiopathogenesis of the bronchialasthma and the increased number of asthma attacks.

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. dos Santos JM. Inhaled corticosteroids in childhood asthma. Pediatr Pulmonol Suppl 1997;16:98-100.
2. Holgate ST. The cellular and mediator basis of asthma in relation to natural history. Lancet 1997;350 Suppl 2:SII5-9.
3. Paldanius M, Juvonen R, Leinonen M, Bloigu A, Silvennoinen-Kassinen S, Saikku P. Asthmatic persons are prone to the persistence of Chlamydia pneumoniae anti- bodies. Diagn Microbiol Infect Dis 2007;59:117-22.
4. Liu AH. Biomarkers and childhood asthma: improving control today and tomor- row. Allergy Asthma Proc 2005;26:249-54.
5. Busse WW. The relationship between viral infections and onset of allergic diseases and asthma. Clin Exp Allergy 1989;19:1-9.
6. Weigl JA, Puppe W, Meyer CU, Berner R, Forster J, Schmitt HJ, et al. Ten years experience with year-round active surveillance of up to 19 respiratory pathogens in children. Eur J Pediatr 2007;166:957-66.
7. Sung RY, Chan PK, Tsen T, Li AM, Lam WY, Yeung AC, et al. Identifcation of viral and atypical bacterial pathogens in children hospitalized with acute respiratory infections in Hong Kong by multiplex PCR assays. J Med Virol 2009;81:153-9.
8. Airenne S, Surcel HM, Alakarppa H, Laitinen K, Paavonen J, Saikku P, et al. Chla- mydia pneumoniae infection in human monocytes. Infect Immun 1999;67:1445-9.
9. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:1501-7.
10. Kraf M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998;158:998-1001.
11. Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14:178-82.
12. Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chla- mydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998;11:345-9.
13. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-20.
14. Black PN, Scicchitano R, Jenkins CR, Blasi F, Allegra L, Wlodarczyk J, et al. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J 2000;15:254-9.
15. Shemer-Avni Y, Lieberman D. Chlamydia pneumoniae-induced ciliostasis in cili- ated bronchial epithelial cells. J Infect Dis 1995;171:1274-8.
16. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996;64:4872-5.
17. Rodel J, Woytas M, Groh A, Schmidt KH, Hartmann M, Lehmann M, et al. Production of basic fbroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 2000;68:3635-41.
18. Von Hertzen L, Töyrylä M, Gimishanov A, Bloigu A, Leinonen M, Saikku P, et al. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy 1999;29:522-8.
19. Hahn DL, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann Allergy Asthma Immunol 1998;81:339-44.
20. Sabato AR, Töyrylä M, Gimishanov A, Bloigu A, Leinonen M, Saikku P, et al. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child 1984;59:1034-7.
21. Shearman MJ, Cubie HA, Inglis JM. Mycoplasma pneumoniae infection: early diagnosis by detection of specifc IgM by immunofuorescence. Br J Biomed Sci 1993;50:305-8.
22. Skaug K, Eng J, Orstavik I, Haug KW. The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofuorescent antibody test. Acta Pathol Microbiol Scand B 1976;84:170-6.
23. Woolcock AJ, Peat J. What is the relationship between airway hyperresponsiveness and atopy? Am J Respir Crit Care Med 2000;161:S215-7.
24. Shirakawa I, Deichmann KA, Izuhara I, Mao I, Adra CN, Hopkin JM. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000;21:60- 4.
25. Jenkins MA, Hopper JL, Bowes G, Carlin JB, Flander LB, Giles GG. Factors in childhood as predictors of asthma in adult life. BMJ 1994;309:90-3.
26. Douglass JA, OHehir RE. What determines asthma phenotype? Respiratory infections and asthma. Am J Respir Crit Care Med 2000;161:S211-4.
27. Host A, Halken S. The role of allergy in childhood asthma. Allergy 2000;55:600- 8.
28. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-9.
29. Teig N, Anders A, Schmidt C, Rieger C, Gatermann S. Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax 2005;60:962-6.
30. Hanhan U, Orlowski J, Fiallos M. Association of Mycoplasma pneumoniae infections with status asthmaticus. Open Respir Med J 2008;2:35-8.
31. Emre U, Sokolovskaya N, Roblin PM, Schachter J, Hammerschlag MR. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995;172:265-7.
32. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991;266:225-30.
33. Korppi M, Halonen P, Kleemola M, Launiala K. Viral fndings in children under the age of two years with expiratory difculties. Acta Paediatr Scand 1986;75:457-64.
34. Korppi M. Bacterial infections and pediatric asthma. Immunol Allergy Clin North Am.30:565-574, vii.
35. Mycoplasma pneumoniae. Lancet 1991;337:651-2.
36. Dalhof K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and infammatory response. Am J Respir Cell Mol Biol 1998;19:721-7.
37. Stick SM , Burton PR, Gurrin L, Sly PD, LeSouëf PN. Efects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996;348:1060-4.
38. Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneu- moniae from asthmatic patients. Ann Allergy 1993;70:23-5.

APA	TUTANÇ M, GÜRKAN M, YEL S, GÜNEŞ A, Konca Ç, BİLEN G (2015). Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. , 353 - 357.
Chicago	TUTANÇ Murat,GÜRKAN M. Fuat,YEL Servet,GÜNEŞ Ali,Konca Çapan,BİLEN Gülseren Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. (2015): 353 - 357.
MLA	TUTANÇ Murat,GÜRKAN M. Fuat,YEL Servet,GÜNEŞ Ali,Konca Çapan,BİLEN Gülseren Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. , 2015, ss.353 - 357.
AMA	TUTANÇ M,GÜRKAN M,YEL S,GÜNEŞ A,Konca Ç,BİLEN G Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. . 2015; 353 - 357.
Vancouver	TUTANÇ M,GÜRKAN M,YEL S,GÜNEŞ A,Konca Ç,BİLEN G Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. . 2015; 353 - 357.
IEEE	TUTANÇ M,GÜRKAN M,YEL S,GÜNEŞ A,Konca Ç,BİLEN G "Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children." , ss.353 - 357, 2015.
ISNAD	TUTANÇ, Murat vd. "Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children". (2015), 353-357.

APA	TUTANÇ M, GÜRKAN M, YEL S, GÜNEŞ A, Konca Ç, BİLEN G (2015). Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. Journal of Clinical and Analytical Medicine, 6(3), 353 - 357.
Chicago	TUTANÇ Murat,GÜRKAN M. Fuat,YEL Servet,GÜNEŞ Ali,Konca Çapan,BİLEN Gülseren Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. Journal of Clinical and Analytical Medicine 6, no.3 (2015): 353 - 357.
MLA	TUTANÇ Murat,GÜRKAN M. Fuat,YEL Servet,GÜNEŞ Ali,Konca Çapan,BİLEN Gülseren Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. Journal of Clinical and Analytical Medicine, vol.6, no.3, 2015, ss.353 - 357.
AMA	TUTANÇ M,GÜRKAN M,YEL S,GÜNEŞ A,Konca Ç,BİLEN G Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. Journal of Clinical and Analytical Medicine. 2015; 6(3): 353 - 357.
Vancouver	TUTANÇ M,GÜRKAN M,YEL S,GÜNEŞ A,Konca Ç,BİLEN G Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children. Journal of Clinical and Analytical Medicine. 2015; 6(3): 353 - 357.
IEEE	TUTANÇ M,GÜRKAN M,YEL S,GÜNEŞ A,Konca Ç,BİLEN G "Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children." Journal of Clinical and Analytical Medicine, 6, ss.353 - 357, 2015.
ISNAD	TUTANÇ, Murat vd. "Seropositivity for chlamydia pneumoniae and mycoplasma pneumoniae in asthmatic children". Journal of Clinical and Analytical Medicine 6/3 (2015), 353-357.